Cronos Group (TSE:CRON) Trading Up 1.4% – Should You Buy?

Cronos Group Inc. (TSE:CRON)’s share price traded up 1.4% during trading on Tuesday . The stock traded as high as C$3.56 and last traded at C$3.55. 115,604 shares changed hands during mid-day trading, a decline of 32% from the average session volume of 169,199 shares. The stock had previously closed at C$3.50.

Analyst Ratings Changes

A number of research analysts have commented on CRON shares. Canaccord Genuity Group set a C$4.25 target price on shares of Cronos Group and gave the company a “buy” rating in a research report on Tuesday, January 27th. TD Securities set a C$4.50 price target on shares of Cronos Group and gave the company a “buy” rating in a research report on Tuesday, February 24th. Two equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of C$4.38.

Cronos Group Price Performance

The company has a market cap of C$1.35 billion, a price-to-earnings ratio of -177.50, a P/E/G ratio of 0.12 and a beta of 1.18. The company’s 50-day simple moving average is C$3.59 and its 200-day simple moving average is C$3.60. The company has a debt-to-equity ratio of 0.25, a current ratio of 19.59 and a quick ratio of 24.01.

About Cronos Group

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S.